Manufacturer record
Lesanto Laboratories: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Lesanto Laboratories (Maharashtra) was declared Not of Standard Quality in March 2020. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: LL484103, Ibuprofen Tablets IP 400mg (exp Aug 2022). CDTL Mumbai (CDSCO lab) found it not of standard quality: Dissolution. Listed in the March 2020 alert.
Records by type
1 record linked to Lesanto Laboratories in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Ibuprofen Tablets IP 400mg | Batch LL484103Mfg Sep 2019 · Exp Aug 2022 | DissolutionDissolution | CDTL MumbaiCDSCO lab | Mar 2020 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.